FLU VACCINES
March 1st, 2003
BY KEITH NUTHALLINFORMAL guidelines have been drawn up by the Committee for Proprietary Medicinal Products of the European Agency for the Evaluation of Medicinal Products (EMEA) on the production of live attenuated influenza vaccines. In an introduction to the note, the committee says that existing inactivated flu vaccines guidelines do note address the requirements of producing these live medicines "in embryonated eggs based on cold-adapted influenza virus master strains." As a result, this new paper suggests, for example, that "storage conditions of seed lots ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.